30 results
ARS
2023 FY
XFOR
X4 Pharmaceuticals Inc
29 Apr 24
Annual report to shareholders
4:58pm
facility or us, including requiring recall or withdrawal of the product from the market or suspension of manufacturing. If we, our product candidates … or export of products, or require us to initiate a product recall. The occurrence of any event or penalty described above, or any other sanction
8-K
EX-1.1
pgtcr72
9 Dec 22
X4 Pharmaceuticals Announces Proposed Public Offering
8:46am
8-K
EX-1.1
b10pq
27 Nov 19
X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class B Warrants
5:18pm
8-K
EX-1.1
82vj3rrvllbly8nhx
15 Apr 19
X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants
4:41pm